https://mattstrongalldaylong.com/reflexology-for-the-win/ 2026-05-29T02:20:35+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/reflexology-foot-massage-3.png https://mattstrongalldaylong.com/oncologist-visit-the-waiting-is-the-hardest-part/ 2026-05-29T02:20:46+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/sarcoma-clock.jpg https://mattstrongalldaylong.com/wp-content/uploads/2026/05/bcc-clinical-trial.png https://mattstrongalldaylong.com/oncologist-visit-5-19-26-strength-runs-on-hope/ 2026-05-29T02:20:57+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/strength-runs-on-hope.png https://mattstrongalldaylong.com/celebrating-the-end-of-chemo-week-with-a-shot/ 2026-05-29T02:21:08+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/filgrastim-3.png https://mattstrongalldaylong.com/chemotherapy-begins-the-return-of-mayor-matt/ 2026-05-29T02:21:48+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/mayor-matts-room-3.jpg https://mattstrongalldaylong.com/pet-and-ct-scans-may-help-predict-outcomes-in-bone-sarcoma/ 2026-05-29T02:33:09+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/PET-And-CT-Scans-May-Help-Predict-Outcomes-In-Bone-Sarcoma-v2-.png https://mattstrongalldaylong.com/oncologist-visit-counts-go-up-and-pain-goes-down/ 2026-05-29T10:56:28+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2027/05/calculating-when-pain-will-go-away3.jpg https://mattstrongalldaylong.com/genomic-tumor-profiling-is-transforming-the-diagnosis-and-treatment-of-pediatric-soft-tissue-sarcomas/ 2026-05-29T11:10:33+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/Genomic-Tumor-Profiling-Is-Transforming-The-Diagnosis-And-Treatment-Of-Pediatric-Soft-Tissue-Sarcomas.png https://mattstrongalldaylong.com/new-biomarker-identified-for-response-to-a-specific-childhood-cancer-therapy/ 2026-05-30T11:31:35+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/New-Biomarker-Identified-For-Response-To-A-Specific-Childhood-Cancer-Therapy.jpg https://mattstrongalldaylong.com/healthy-lifestyle-choices-can-reduce-chronic-health-risks-for-childhood-cancer-survivors/ 2026-05-31T12:03:36+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/Healthy-Lifestyle-Choices-Can-Reduce-Chronic-Health-Risks-For-Childhood-Cancer-Survivors.jpg https://mattstrongalldaylong.com/movin-on-up/ 2026-06-04T10:25:07+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/matt-studying-3.jpg https://mattstrongalldaylong.com/radiation-mapping-562026/ 2026-06-04T10:27:03+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/05/radiation-therapy-system.jpg https://mattstrongalldaylong.com/cardiologist-telehealth-call-5526/ 2026-06-04T10:28:45+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/echocardiogram-machine.jpg https://mattstrongalldaylong.com/oncologist-visit-5426/ 2026-06-04T10:30:13+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/st-josephs-childrens-hospital.jpg https://mattstrongalldaylong.com/latest-scans-back-to-kicking-cancers-butt/ 2026-06-04T12:08:14+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/time-to-kick-cancers-butt-v7.jpg https://mattstrongalldaylong.com/transcription-factor-targeting-advances-pediatric-cancer-treatment/ 2026-06-05T11:49:58+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Transcription-Factor-Targeting-Advances-Pediatric-Cancer-Treatment.jpg https://mattstrongalldaylong.com/one-therapy-that-could-potentially-stop-ewing-sarcoma-at-the-source/ 2026-06-05T19:52:48+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/One-Therapy-That-Could-Potentially-Stop-Ewing-Sarcoma-At-The-Source.jpg https://mattstrongalldaylong.com/new-phase-1-mettseo-clinical-trial-for-newly-diagnosed-and-widely-metastatic-ewing-sarcoma/ 2026-06-07T11:45:02+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/New-Phase-1-METTSEO-Clinical-Trial-For-Newly-Diagnosed-And-Widely-Metastatic-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/clinical-trial-day-one-the-hope-that-is-dfmo/ 2026-06-08T23:29:00+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/matt-with-dfmo.jpg https://mattstrongalldaylong.com/uba1-serves-as-a-therapeutic-target-in-ewing-sarcoma/ 2026-06-09T18:13:06+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/UBA1-Serves-As-A-Therapeutic-Target-In-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/new-options-for-patients-with-sarcoma/ 2026-06-09T18:24:53+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/New-Options-For-Patients-With-Sarcoma.jpg https://mattstrongalldaylong.com/abemaciclib-shows-benefit-in-dedifferentiated-liposarcoma/ 2026-06-09T19:06:18+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Abemaciclib-Shows-Benefit-in-Dedifferentiated-Liposarcoma.jpg https://mattstrongalldaylong.com/targeting-cxadr-suppresses-tumorigenesis-and-enhances-chemotherapy-efficacy-in-ewing-sarcoma/ 2026-06-10T11:39:23+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Targeting-CXADR-Suppresses-Tumorigenesis-And-Enhances-Chemotherapy-Efficacy-In-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/targeting-exo1-represents-a-promising-therapeutic-option-for-ewing-sarcoma/ 2026-06-11T11:17:43+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Targeting-EXO1-Represents-A-Promising-Therapeutic-Option-For-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/atr-chk1-wee1-pathway-inhibition-induces-cell-death-in-ewing-sarcoma-cells-experiencing-dna-replication-stress/ 2026-06-11T11:37:50+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/ATR-CHK1-WEE1-Pathway-Inhibition-Induces-Cell-Death-In-Ewing-Sarcoma-Cells-Experiencing-DNA-Replication-Stress.jpg https://mattstrongalldaylong.com/american-society-of-clinical-oncology-pushes-to-remove-barriers-for-pediatric-oncology-clinical-trials/ 2026-06-12T11:29:18+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/American-Society-of-Clinical-Oncology-Pushes-To-Remove-Barriers-For-Pediatric-Oncology-Clinical-Trials.jpg https://mattstrongalldaylong.com/targeting-the-cd47-sirp%ce%b1-axis-shows-potential-for-promoting-antitumor-efficacy-in-solid-tumors/ 2026-06-13T11:27:46+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Targeting-the-CD47-SIRP%CE%B1-Axis-Shows-Potential-For-Promoting-Antitumor-Efficacy-In-Solid-Tumors.jpg https://mattstrongalldaylong.com/circulating-igf2bp3-can-help-predict-treatment-response-in-ewing-sarcoma/ 2026-06-13T11:47:28+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Circulating-IGF2BP3-Can-Help-Predict-Treatment-Response-In-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/fda-agrees-to-review-ozekibart-for-metastatic-chondrosarcoma/ 2026-06-16T11:01:19+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/FDA-Agrees-To-Review-Ozekibart-For-Metastatic-Chondrosarcoma.jpg https://mattstrongalldaylong.com/researchers-discover-new-gene-linked-to-kaposis-sarcoma/ 2026-06-17T12:38:53+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Researchers-Discover-New-Gene-Linked-To-Kaposis-Sarcoma.jpg https://mattstrongalldaylong.com/blocking-mdm2-could-be-the-key-to-stopping-some-pediatric-sarcomas/ 2026-06-20T11:27:38+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Blocking-MDM2-Could-Be-The-Key-To-Stopping-Some-Pediatric-Sarcomas.jpg https://mattstrongalldaylong.com/combined-inhibition-of-cdk4-6-and-pi3k-pathways-shows-potential-in-ewing-sarcoma/ 2026-06-20T11:57:04+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Combined-Inhibition-Of-CDK4-6-And-PI3K-Pathways-Shows-Potential-In-Ewing-Sarcoma.jpg https://mattstrongalldaylong.com/halfway-there-livin-on-a-prayer/ 2026-06-22T21:02:54+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/clinical-trial-progress.jpg https://mattstrongalldaylong.com/fda-grants-full-approval-of-tecelra-to-children-battling-synovial-sarcoma/ 2026-06-23T11:10:13+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/FDA-Grants-Full-Approval-Of-Tecelra-To-Children-Battling-Synovial-Sarcoma.jpg https://mattstrongalldaylong.com/rice-bioengineer-wins-federal-grant-for-ewing-sarcoma-research/ 2026-06-24T11:59:09+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/Rice-Bioengineer-Wins-Federal-Grant-For-Ewing-Sarcoma-Research.jpg https://mattstrongalldaylong.com/ctdna-sequencing-could-identify-osteosarcoma-relapse-months-before-any-scan-is-able-to/ 2026-06-27T11:22:15+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/ctDNA-Sequencing-Could-Identify-Osteosarcoma-Relapse-Months-Before-Any-Scan-Is-Able-To.jpg https://mattstrongalldaylong.com/a-greeting-like-no-other/ 2026-06-28T12:15:45+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/matt-and-infusion-center-staff-v2.jpg https://mattstrongalldaylong.com/new-web-address-for-matt-strong-all-day-long/ 2026-06-28T12:37:25+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/important-notice-v2.jpg https://mattstrongalldaylong.com/round-four-delayed-a-week-off/ 2026-06-29T23:35:20+00:00 https://mattstrongalldaylong.com/wp-content/uploads/2026/06/round-four-delayed-a-week-off.jpg